| Matthew Christensen, | |
|
44201 Dequindre Rd Ste Ec, Troy, MI 48085-1117 | |
| (248) 964-5111 | |
| Not Available |
| Full Name | Matthew Christensen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 17 Years |
| Location | 44201 Dequindre Rd Ste Ec, Troy, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104025055 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301090078 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
News Archive
A novel liquid surface coating on human catheters could help reduce protein deposition that leads to urinary tract and bloodstream infections, according to researchers at the University of Maine and University of Notre Dame who are leading a study funded by the National Institutes of Health.
There is an urgent need for medical agents to treat metastatic tumors. In case of pancreatic cancer, one of the most aggressive types of cancer that is often detected late, 95% of the patients die within five years after the diagnosis.
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
› Verified 9 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
A novel liquid surface coating on human catheters could help reduce protein deposition that leads to urinary tract and bloodstream infections, according to researchers at the University of Maine and University of Notre Dame who are leading a study funded by the National Institutes of Health.
There is an urgent need for medical agents to treat metastatic tumors. In case of pancreatic cancer, one of the most aggressive types of cancer that is often detected late, 95% of the patients die within five years after the diagnosis.
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Christensen, 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: () - | Matthew Christensen, 44201 Dequindre Rd Ste Ec, Troy, MI 48085-1117 Ph: (248) 964-5111 |
News Archive
A novel liquid surface coating on human catheters could help reduce protein deposition that leads to urinary tract and bloodstream infections, according to researchers at the University of Maine and University of Notre Dame who are leading a study funded by the National Institutes of Health.
There is an urgent need for medical agents to treat metastatic tumors. In case of pancreatic cancer, one of the most aggressive types of cancer that is often detected late, 95% of the patients die within five years after the diagnosis.
GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that it has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss a proposed IND for GeoVax's therapeutic vaccine as a treatment for individuals infected with HIV/AIDS.
The International Committee of Medical Journal Editors (ICMJE) issued a statement today that the 11 member journals will require, as a condition of consideration for publication, registration in a public trials registry for clinical studies involving human patients.
Researchers at MIT and Brigham and Women's Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
› Verified 9 days ago
David Donaldson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Ec, Troy, MI 48085 Phone: 248-964-8787 | |
Philip O Kilanowski-doroh, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5111 | |
Cristina Geneva Bruno, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 44201 Dequindre Rd, Troy, MI 48085 Phone: 248-964-5000 | |
Adam Sylvester Kur Iii, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 44201 Dequindre Rd, Ec, Troy, MI 48085 Phone: 248-964-5000 | |
Stephen M. Smith, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 44201 Dequindre Rd Ste Ec, Troy, MI 48085 Phone: 248-964-5111 | |
Dema Fawaz, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 44201 Dequindre Rd Ste Ec, Troy, MI 48085 Phone: 248-964-5111 |